Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a large drop in short interest in December. As of December 31st, there was short interest totaling 1,558 shares, a drop of 38.3% from the December 15th total of 2,524 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 3,750 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily volume of 3,750 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.1% of the shares of the stock are short sold.

Fidelity Disruptive Medicine ETF Stock Performance

FMED stock traded down $0.05 during trading on Friday, reaching $27.47. 3,952 shares of the company were exchanged, compared to its average volume of 9,823. The stock’s 50 day moving average price is $27.62 and its 200 day moving average price is $25.72. Fidelity Disruptive Medicine ETF has a 52-week low of $20.69 and a 52-week high of $29.07. The company has a market cap of $63.18 million, a P/E ratio of 41.33 and a beta of 1.00.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

An institutional investor recently raised its position in Fidelity Disruptive Medicine ETF stock. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 12.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 688,750 shares of the company’s stock after purchasing an additional 76,538 shares during the period. Wealth Enhancement Advisory Services LLC owned about 31.31% of Fidelity Disruptive Medicine ETF worth $16,544,000 as of its most recent SEC filing.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.